ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 821

Trends in Incidence and Prevalence of Osteoarthritis in the United Kingdom: Findings from the Clinical Practice Research Datalink (CPRD)

Subhashisa Swain1, Aliya Sarmanova 2, Christian Mallen 3, Chang Fu Kuo 4, Carol Coupland 5 and Weiya Zhang 6, 1University of Nottingham, Nottingham, England, United Kingdom, 22. Bristol Medical School, Population Health Sciences, University of Bristol, UK, Bristol, England, United Kingdom, 3Research Institute for Primary Care and Health Sciences, Keele University, UK, Keele, United Kingdom, 44. Division of Rheumatology, Allergy and Immunology, Chang Gung Memorial Hospital, Taoyuan 333, Taiwan (Republic of China), 55. Division of Primary Care, School of Medicine, University of Nottingham, Nottingham, England, United Kingdom, 61. Academic Rheumatology, Division of Rheumatology, Orthopaedics and Dermatology, University of Nottingham, Nottingham, England, United Kingdom

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Big data, Epidemiologic methods, Osteoarthritis, physician data and trend

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: 3S074: Epidemiology & Public Health I: Risk Factors & Outcomes for Rheumatic Diseases (821–826)

Session Type: ACR Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Osteoarthritis (OA) is by far the most common arthritis.(1) However,  its chronological trend in the United Kingdom (UK) is not known. We aimed to explore the trend in both incidence and prevalence of OA among adults aged 20 years or more in the UK during the period 1997-2017 using a large nationally representative primary care database.

Methods: The UK Clinical Practice Research Datalink (CPRD), comprising data on 17 million patients, was used for this study (2). We estimated the incidence and prevalence of general practitioner (GP) diagnosed OA (both overall and joint-specific: hip, knee, ankle/foot, wrist/hand and unspecified site) which was age-sex standardized using 2017 UK mid-year population. Joinpoint analysis was performed to identify the trend points. Geographical distribution was mapped according to the different regions in the UK. The data used for the study is recorded by the GPs in UK, and nearly 100% patients would have met the ACR classification criteria.

Results: During the year 1997-2017, 608,350 incident OA cases aged >20 years were recorded. In 2017, the standardized prevalence of GP-diagnosed OA for any joint in both sexes was 10.44% (95% CI 10.39%-10.49%), 12.49%; 95% CI 12.41%-12.56%) in women and 8.28% (95%CI 8.22%-8.35%) in men. The prevalence recorded according to body site was unspecified joint (7.32%), knee (2.76%), hip (1.17%), wrist/hand (0.52%) and foot/ankle (0.29%). The prevalence of any-OA increased from 4.9% in 1997 to 10.4% in 2017 with average annual percentage increase of 3.9% (95% CI 3.5-4.2%). (Figure-1) The standardised incidence of any OA in both sexes in 2017 was 7.5 per 1000 person-years (95% CI 7.4-7.6 per 1000 person-years), 9.0 per 1000 person-years (95% CI 8.8-9.2 per 1000 person-years) in women and 5.8 per 1000 person-years (95% CI 5.7-6.0 per 1000 person-years) in men. In 2017, the incidence recorded in joints was: unspecified site OA (5.2 per 1000 person-years), followed by knee (2.3 per 1000 person-years), hip (1.1 per 1000 person-years), wrist/hand (0.68 per 1000 person-years) and foot/ankle (0.19 per 1000 person-years) OA. The incidence of any OA decreased from 10.8 per 1000 person-years (95% CI 10.7-11.0 per 1000 person-years) in 1997 to 7.5 per 1000 person-years (95% CI 7.4-7.6 1000 person-years) in 2017 with an average annual percentage reduction of -1.7% (95%CI -2.6 to -0.8). (Figure-2) The prevalence and incidence varied across the UK, with the northern region had higher OA prevalence and incidence compared to the rest of the UK in 2014 with few exceptions. (Figure-3)

Conclusion: In the UK approximately one in 10 adults have clinically diagnosed OA.  The knee is the commonest recorded site for OA that results in GP consultation. While the prevalence has increased, incidence has decreased in this population in the past 20 years. Further research is needed to understand these changes.

 Reference:

  1. Litwic A, Edwards MH, Dennison EM, Cooper C. Epidemiology and burden of osteoarthritis. Br Med Bull. 2013;105:185-99.
  2. Herrett E, Gallagher AM, Bhaskaran K, Forbes H, Mathur R, van Staa T, et al. Data Resource Profile: Clinical Practice Research Datalink (CPRD). Int J Epidemiol. 2015;44(3):827-36.

Figure-1 Trends of standardized prevalence of GP diagnosed OA in the UK 1997-2017

For men and women- Age standardized; Both- Age and sex standardized

Figure-2 Trends in standardized incidence of GP diagnosed OA in the UK -1997-2017-

For men and women- Age standardized; Both- Age and sex standardized

Figure-3 Prevalence and incidence of GP-diagnosed OA in different regions of the UK in 2014

The contribution from East Midlands region to the CPRD-GOLD database used in the study was nearly zero, which did not allow to have whole country representation for the year 2017.


Disclosure: S. Swain, None; A. Sarmanova, None; C. Mallen, None; C. Kuo, None; C. Coupland, None; W. Zhang, None.

To cite this abstract in AMA style:

Swain S, Sarmanova A, Mallen C, Kuo C, Coupland C, Zhang W. Trends in Incidence and Prevalence of Osteoarthritis in the United Kingdom: Findings from the Clinical Practice Research Datalink (CPRD) [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/trends-in-incidence-and-prevalence-of-osteoarthritis-in-the-united-kingdom-findings-from-the-clinical-practice-research-datalink-cprd/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/trends-in-incidence-and-prevalence-of-osteoarthritis-in-the-united-kingdom-findings-from-the-clinical-practice-research-datalink-cprd/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology